GI-Map Stool Test
Understanding the GI-MAP with Zonulin: A Comprehensive View of Gut Health
The gastrointestinal system plays a central role in digestion, immune regulation and overall wellbeing. As research into the gut microbiome continues to expand, advanced diagnostic testing is helping practitioners gain deeper insight into the complex relationship between microbes, intestinal function and health outcomes. One such assessment is the GI-MAP with zonulin test.
The Gastrointestinal Microbial Assay Plus (GI-MAP) with zonulin is an advanced stool analysis that evaluates gastrointestinal microbiota DNA together with important immune, digestive and intestinal barrier markers from a single stool sample. Using quantitative polymerase chain reaction (qPCR) technology, the test provides a detailed assessment of microbial balance and factors that may contribute to gastrointestinal dysfunction.
What Does the GI-MAP with Zonulin Measure?
The GI-MAP panel examines a broad range of microorganisms and functional markers associated with gut health. This includes:
Pathogenic bacteria
Commensal (beneficial) bacteria
Opportunistic organisms
Fungi and yeast
Viruses
Parasites
In addition to microbial analysis, the test evaluates several key markers involved in digestive and immune function, including:
Calprotectin – associated with intestinal inflammation
Secretory IgA (sIgA) – an indicator of mucosal immune activity
Pancreatic elastase – a marker of digestive enzyme production and pancreatic function
Zonulin – a protein associated with regulation of intestinal barrier integrity
Together, these markers provide a broader picture of gastrointestinal health and how microbial patterns may relate to digestive symptoms or wider systemic presentations.
Why Is Gut Barrier Function Important?
Intestinal Permeability (“Leaky Gut”)
The GI-MAP with zonulin includes assessment of intestinal permeability, commonly referred to as “leaky gut”. This relates to how well the lining of the gut acts as a protective barrier, allowing nutrients to be absorbed while helping to keep unwanted substances, toxins and microbes from passing into the bloodstream.
When the gut lining becomes more permeable than it should be, it may contribute to inflammation, digestive symptoms and wider health concerns in some individuals. Measuring zonulin, a protein involved in regulating the gut lining, can provide additional insight into gut barrier health as part of a broader functional assessment.
The Benefits of qPCR Technology
Unlike traditional stool culture methods, the GI-MAP uses quantitative polymerase chain reaction (qPCR) technology to detect microbial DNA with a high level of sensitivity and specificity:
Identify microbial imbalances more precisely
Monitor changes in microbial patterns over time
Evaluate responses to dietary, lifestyle or therapeutic interventions
This can be especially useful when tracking progress as part of a personalised gut health programme.
A More Comprehensive Approach to Gut Health
The GI-MAP with zonulin combines microbial analysis with immune, digestive and intestinal barrier markers to provide a broader understanding of gastrointestinal function. By examining both microbiota patterns and functional biomarkers, the test may help guide more personalised strategies aimed at supporting digestive health and overall wellbeing.
As our understanding of the gut microbiome continues to evolve, tools like the GI-MAP are becoming increasingly valuable in exploring the connections between gut function, immunity and long-term health.
Who May Benefit from GI-MAP with Zonulin Testing?
Digestive Symptoms
Individuals experiencing ongoing digestive complaints may benefit from a more detailed assessment of gut function and microbial balance. Common symptoms include:
Chronic diarrhoea
Constipation
Bloating
Excessive gas
Abdominal discomfort or pain
These symptoms can sometimes be associated with microbial imbalances, inflammation or impaired digestive function.
Altered Bowel Habits
Changes in stool frequency, urgency or consistency may indicate disruption within the gastrointestinal environment. The GI-MAP can help explore potential microbial or functional contributors to ongoing bowel irregularities.
Suspected Gastrointestinal Disorders
The test may be used as part of a broader clinical evaluation in presentations such as:
Irritable bowel syndrome (IBS)
Inflammatory bowel disease (IBD)
Coeliac disease
While the GI-MAP is not intended to diagnose these conditions independently, it may provide complementary information regarding gut microbiota, inflammation and digestive function.
Recurrent Gastrointestinal Symptoms
Persistent or recurring digestive symptoms may warrant investigation into potential bacterial contributors, including organisms such as:
Escherichia coli
Helicobacter pylori
Identifying microbial patterns may help support more targeted clinical decision-making.
Malabsorption Concerns
The GI-MAP may also be considered where there are signs suggestive of impaired nutrient absorption, including:
Unexplained weight loss
Anaemia
Nutrient insufficiencies
Immune-Related Conditions
Emerging research continues to explore the relationship between the gut microbiome and immune regulation. Gastrointestinal assessment may therefore be relevant in some autoimmune or inflammatory conditions where gut-related factors are suspected to contribute to symptom patterns.
Skin Conditions
Eczema
Acne
Psoriasis
Fatigue and Neurological Symptoms
Brain fog
Fatigue
Low energy
Mood changes
Supporting a Personalised Clinical Approach
Because gastrointestinal health is highly individual, GI-MAP results are interpreted alongside symptoms, clinical history, dietary factors and lifestyle influences. The combination of microbial analysis and functional markers can help develop a more personalised strategy to support digestive and overall health.
If you are suffering with any of the Health, Digestive or Skin indications above, the GI-Map Test is available with Sam. Consultation, Analysis, Report and Suggested Plan is all included. Book Here to begin your Gut health journey
About the GI-MAP Test – Comprehensive Stool Testing
The Gastrointestinal Microbial Assay Plus (GI-MAP) stool test was designed to assess a patient’s microbiome from a single stool sample, with particular attention to microbes that may be disturbing normal microbial balance and may contribute to perturbations in the gastrointestinal (GI) flora or illness.
The panel is a comprehensive collection of microbial targets as well as immune and digestive markers. It screens for pathogenic bacteria, commensal bacteria, opportunistic pathogens, fungi, viruses, and parasites. It primarily uses multiplex, automated, DNA analysis to give integrative and functional medicine practitioners a better view into the gastrointestinal microbiome.
INCLUDES: Consultation, Lab Test, Analysis, Report and Suggestions.
gut microbiome